Condrosulf 800
Condrosulf 800 is a medicine authorised by Swissmedic under authorisation number 51610. The authorisation holder is IBSA Institut Biochimique SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 31 October 1991 and the authorisation is valid without a time limit. ATC code M01AX25 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 51610 |
|---|---|
| Name | Condrosulf 800 |
| Full name | Condrosulf 800, compresse |
| Authorisation holder | IBSA Institut Biochimique SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | M01AX25 |
| First authorisation | 31 October 1991 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Condrosulf 800, compresse | B | 31 October 1991 |
| 2 | Condrosulf 400, compresse | B | 24 November 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 16 | 30 | Tablette(n) | M01AX25 | 07.10.6. | B |
| 24 | 90 | Tablette(n) | M01AX25 | 07.10.6. | B |
| 32 | 60 | Tablette(n) | M01AX25 | 07.10.6. | B |
| 40 | 180 | Tablette(n) | M01AX25 | 07.10.6. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Condrosulf 800 authorised in Switzerland?
Yes. Condrosulf 800 is authorised by Swissmedic under authorisation number 51610, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Condrosulf 800 have?
Condrosulf 800 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Condrosulf 800?
The authorisation holder is IBSA Institut Biochimique SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.